|
|
|||
|
||||
OverviewWidely acknowledged as one of the most challenging aspects of dealing with an ageing population, the increasing prevalence of cognitive decline in the elderly presents the clinician with a variety of complex therapeutic problems. Alzheimer's disease and other dementias vary in their onset and progression, as do patients in their responsiveness to treatment. Social management is as important as the choice of therapeutic agent, and implementing effective and sympathetic treatment requires care and sensitivity as well as a sound knowledge of currently available options. In this important new work, leading experts review the therapeutic agents currently available and assess their effectiveness. Also included is an update on recent and on-going clinical trials, the prospects for new therapeutic targets and the development of new biomarkers that will aid recognition of disease and thus earlier intervention. Full Product DetailsAuthor: C. W. Ritchie , Dave Ames , Colin L. Masters , Jeffrey L. CummingsPublisher: Clinical Publishing,an imprint of Atlas Medical Publishing Ltd Imprint: Clinical Publishing,an imprint of Atlas Medical Publishing Ltd Dimensions: Width: 17.00cm , Height: 2.50cm , Length: 24.00cm Weight: 1.043kg ISBN: 9781904392583ISBN 10: 190439258 Pages: 376 Publication Date: 30 October 2006 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: Out of stock The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available. Table of ContentsReviewsAuthor InformationTab Content 6Author Website:Countries AvailableAll regions |